BRÈVE

sur LR Health & Beauty SE (isin : NO0013149658)

LR Health & Beauty Reports Q4 2025 Results and Strategic Initiatives

LR Health & Beauty SE, a leader in digital social commerce based in Ahlen, has published its fourth-quarter 2025 results. The company reported sales of EUR 68.2 million, a 10.9% decline from the previous year's comparable period. Full-year 2025 sales stood at EUR 277.1 million, down 4.6% from 2024. The company attributes these declines to subdued consumer sentiment in Western Europe.

Preliminary EBITDA for the year was EUR 16.5 million, with Q4 2025 contributing only EUR 0.3 million. This reduction in EBITDA is partly due to the realignment of the financing structure. CEO Jörg Körfer emphasized ongoing strategic initiatives to ensure long-term growth, including a planned product launch combining health and beauty expertise in 2026.

LR Health & Beauty continues to develop health and cosmetic products, placing a strong emphasis on sustainability. The company plans to unveil its new product lineup in spring, aiming to revitalize its business strategy and market approach.

R. P.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de LR Health & Beauty SE